Status:
COMPLETED
Risedronate for the Treatment of Osteoporosis for People With Spinal Cord Injury
Lead Sponsor:
Toronto Rehabilitation Institute
Collaborating Sponsors:
The Physicians' Services Incorporated Foundation
St. Joseph's Health Care London
Conditions:
Osteoporosis
Eligibility:
All Genders
18-70 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to find out if risedronate works for the treatment of osteoporosis for people with spinal cord injury.
Eligibility Criteria
Inclusion
- Traumatic spinal cord injury of greater than 18 months
- Osteopenia or osteoporosis of the hip
- Must be able to swallow tablets and sit upright
Exclusion
- Bilateral heterotopic ossification
- Bilateral lower extremity metal implants
- Pregnant or lactating females
- Paget's disease
- Osteomalacia
- Steroid induced bone loss
- Untreated parathyroid or thyroid disease
- Symptomatic hypocalcemia or hypophosphatemia
- Treatment in the last year with calcitonin, fluoride or anabolic steroids
- Current treatment with prednisone
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2009
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT00138866
Start Date
November 1 2004
End Date
March 1 2009
Last Update
October 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Toronto Rehab, Lyndhurst Centre
Toronto, Ontario, Canada, M4G 3V9